10-Q Filing

ALIGNMENT HEALTHCARE, INC. CIK: 1832466 Q1 2024

Filing Information

Form Type	10-Q
Accession Number	`0001628280-24-019994`
Period End Date	20240331
Filing Date	20240502
Fiscal Year	2024
Fiscal Period	Q1
XBRL Instance	alhc-20240331_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 150 Income Statement 80 Cash Flow Statement 142 Stockholders Equity 42

Balance Sheet 150 line items

Line Item	Tag	Value	Unit	Period
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	-	USD	Point-in-time
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	-	USD	Point-in-time
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	-	USD	Point-in-time
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	-	USD	Point-in-time
Preferred stock par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$238.90M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$238.90M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$384.26M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$384.26M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$202.90M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$202.90M	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Accounts receivable (less allowance for credit losses of $0 at March 31, 2024 and December 31, 2023)	`AccountsReceivableNetCurrent`	$165.07M	USD	Point-in-time
Accounts receivable (less allowance for credit losses of $0 at March 31, 2024 and December 31, 2023)	`AccountsReceivableNetCurrent`	$165.07M	USD	Point-in-time
Accounts receivable (less allowance for credit losses of $0 at March 31, 2024 and December 31, 2023)	`AccountsReceivableNetCurrent`	$119.75M	USD	Point-in-time
Accounts receivable (less allowance for credit losses of $0 at March 31, 2024 and December 31, 2023)	`AccountsReceivableNetCurrent`	$119.75M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Investments - current	`ShortTermInvestments`	$62.81M	USD	Point-in-time
Investments - current	`ShortTermInvestments`	$62.81M	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Investments - current	`ShortTermInvestments`	$115.91M	USD	Point-in-time
Investments - current	`ShortTermInvestments`	$115.91M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$44.97M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$44.97M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$53.86M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$53.86M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$483.54M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$483.54M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$520.64M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$520.64M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	191.16M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	191.16M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$51.90M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$51.90M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$57.21M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$57.21M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	188.95M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	188.95M	shares	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$9.96M	USD	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$9.96M	USD	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$8.55M	USD	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$8.55M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	191.16M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	191.16M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	188.95M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	188.95M	shares	Point-in-time
Goodwill	`Goodwill`	$34.83M	USD	Point-in-time
Goodwill	`Goodwill`	$34.83M	USD	Point-in-time
Goodwill	`Goodwill`	$34.83M	USD	Point-in-time
Goodwill	`Goodwill`	$34.83M	USD	Point-in-time
Intangible Assets, net	`IntangibleAssetsNetExcludingGoodwill`	$5.22M	USD	Point-in-time
Intangible Assets, net	`IntangibleAssetsNetExcludingGoodwill`	$5.22M	USD	Point-in-time
Intangible Assets, net	`IntangibleAssetsNetExcludingGoodwill`	$5.25M	USD	Point-in-time
Intangible Assets, net	`IntangibleAssetsNetExcludingGoodwill`	$5.25M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$6.41M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$6.41M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$6.78M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$6.78M	USD	Point-in-time
Total assets	`Assets`	$633.23M	USD	Point-in-time
Total assets	`Assets`	$633.23M	USD	Point-in-time
Total assets	`Assets`	$591.88M	USD	Point-in-time
Total assets	`Assets`	$591.88M	USD	Point-in-time
Medical expenses payable	`MedicalExpensesPayableCurrent`	$276.46M	USD	Point-in-time
Medical expenses payable	`MedicalExpensesPayableCurrent`	$276.46M	USD	Point-in-time
Medical expenses payable	`MedicalExpensesPayableCurrent`	$205.40M	USD	Point-in-time
Medical expenses payable	`MedicalExpensesPayableCurrent`	$205.40M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$23.51M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$23.51M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$22.67M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$22.67M	USD	Point-in-time
Accrued compensation	`AccruedCompensation`	$31.61M	USD	Point-in-time
Accrued compensation	`AccruedCompensation`	$31.61M	USD	Point-in-time
Accrued compensation	`AccruedCompensation`	$34.11M	USD	Point-in-time
Accrued compensation	`AccruedCompensation`	$34.11M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$263.02M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$263.02M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$330.74M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$330.74M	USD	Point-in-time
Long-term debt, net of debt issuance costs	`LongTermDebtNoncurrent`	$162.03M	USD	Point-in-time
Long-term debt, net of debt issuance costs	`LongTermDebtNoncurrent`	$162.03M	USD	Point-in-time
Long-term debt, net of debt issuance costs	`LongTermDebtNoncurrent`	$161.81M	USD	Point-in-time
Long-term debt, net of debt issuance costs	`LongTermDebtNoncurrent`	$161.81M	USD	Point-in-time
Long-term portion of lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$8.44M	USD	Point-in-time
Long-term portion of lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$8.44M	USD	Point-in-time
Long-term portion of lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$8.97M	USD	Point-in-time
Long-term portion of lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$8.97M	USD	Point-in-time
Total liabilities	`Liabilities`	$501.21M	USD	Point-in-time
Total liabilities	`Liabilities`	$501.21M	USD	Point-in-time
Total liabilities	`Liabilities`	$433.81M	USD	Point-in-time
Total liabilities	`Liabilities`	$433.81M	USD	Point-in-time
Commitments and Contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $.001 par value; $100,000,000 shares authorized as of March 31, 2024 and December 31, 2023, respectively; no shares issued and outstanding as of March 31, 2024 and December 31, 2023	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; $100,000,000 shares authorized as of March 31, 2024 and December 31, 2023, respectively; no shares issued and outstanding as of March 31, 2024 and December 31, 2023	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; $100,000,000 shares authorized as of March 31, 2024 and December 31, 2023, respectively; no shares issued and outstanding as of March 31, 2024 and December 31, 2023	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; $100,000,000 shares authorized as of March 31, 2024 and December 31, 2023, respectively; no shares issued and outstanding as of March 31, 2024 and December 31, 2023	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.001 par value; $1,000,000,000 shares authorized as of March 31, 2024 and December 31, 2023; $191,156,569 and $188,951,643 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	`CommonStockValue`	$191.00K	USD	Point-in-time
Common stock, $.001 par value; $1,000,000,000 shares authorized as of March 31, 2024 and December 31, 2023; $191,156,569 and $188,951,643 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	`CommonStockValue`	$191.00K	USD	Point-in-time
Common stock, $.001 par value; $1,000,000,000 shares authorized as of March 31, 2024 and December 31, 2023; $191,156,569 and $188,951,643 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	`CommonStockValue`	$189.00K	USD	Point-in-time
Common stock, $.001 par value; $1,000,000,000 shares authorized as of March 31, 2024 and December 31, 2023; $191,156,569 and $188,951,643 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	`CommonStockValue`	$189.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.04B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.04B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.06B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.06B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-926.78M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-926.78M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-880.26M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-880.26M	USD	Point-in-time
Total Alignment Healthcare, Inc. stockholders' equity	`StockholdersEquity`	$130.93M	USD	Point-in-time
Total Alignment Healthcare, Inc. stockholders' equity	`StockholdersEquity`	$130.93M	USD	Point-in-time
Total Alignment Healthcare, Inc. stockholders' equity	`StockholdersEquity`	$156.95M	USD	Point-in-time
Total Alignment Healthcare, Inc. stockholders' equity	`StockholdersEquity`	$156.95M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$1.09M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$1.09M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$1.12M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$1.12M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$223.94M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$223.94M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$158.07M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$158.07M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$132.02M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$132.02M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$239.30M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$239.30M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$633.23M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$633.23M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$591.88M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$591.88M	USD	Point-in-time

Income Statement 80 line items

Line Item	Tag	Value	Unit	Period
Earned premiums	`PremiumsEarnedNet`	$621.56M	USD	1 Quarter
Earned premiums	`PremiumsEarnedNet`	$621.56M	USD	1 Quarter
Earned premiums	`PremiumsEarnedNet`	$434.81M	USD	1 Quarter
Earned premiums	`PremiumsEarnedNet`	$434.81M	USD	1 Quarter
Other	`RevenueNotFromContractWithCustomer`	$4.34M	USD	1 Quarter
Other	`RevenueNotFromContractWithCustomer`	$4.34M	USD	1 Quarter
Other	`RevenueNotFromContractWithCustomer`	$7.04M	USD	1 Quarter
Other	`RevenueNotFromContractWithCustomer`	$7.04M	USD	1 Quarter
Total revenues	`Revenues`	$439.15M	USD	1 Quarter
Total revenues	`Revenues`	$439.15M	USD	1 Quarter
Total revenues	`Revenues`	$628.60M	USD	1 Quarter
Total revenues	`Revenues`	$628.60M	USD	1 Quarter
Medical expenses	`MedicalExpenses`	$573.22M	USD	1 Quarter
Medical expenses	`MedicalExpenses`	$573.22M	USD	1 Quarter
Medical expenses	`MedicalExpenses`	$396.31M	USD	1 Quarter
Medical expenses	`MedicalExpenses`	$396.31M	USD	1 Quarter
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$90.51M	USD	1 Quarter
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$90.51M	USD	1 Quarter
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$70.41M	USD	1 Quarter
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$70.41M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$5.98M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$5.98M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$4.92M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$4.92M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$471.64M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$471.64M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$669.71M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$669.71M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-41.11M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-41.11M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-32.49M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-32.49M	USD	1 Quarter
Interest expense	`InterestExpense`	$5.43M	USD	1 Quarter
Interest expense	`InterestExpense`	$5.43M	USD	1 Quarter
Interest expense	`InterestExpense`	$5.02M	USD	1 Quarter
Interest expense	`InterestExpense`	$5.02M	USD	1 Quarter
Other expenses (income)	`OtherNonOperatingExpenseIncome`	$-138.00K	USD	1 Quarter
Other expenses (income)	`OtherNonOperatingExpenseIncome`	$-138.00K	USD	1 Quarter
Other expenses (income)	`OtherNonOperatingExpenseIncome`	$42.00K	USD	1 Quarter
Other expenses (income)	`OtherNonOperatingExpenseIncome`	$42.00K	USD	1 Quarter
Total other expenses	`OtherNonoperatingIncomeExpense`	$-4.88M	USD	1 Quarter
Total other expenses	`OtherNonoperatingIncomeExpense`	$-4.88M	USD	1 Quarter
Total other expenses	`OtherNonoperatingIncomeExpense`	$-5.47M	USD	1 Quarter
Total other expenses	`OtherNonoperatingIncomeExpense`	$-5.47M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-37.37M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-37.37M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-46.58M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-46.58M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$1.00K	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$1.00K	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Net loss	`ProfitLoss`	$-37.37M	USD	1 Quarter
Net loss	`ProfitLoss`	$-37.37M	USD	1 Quarter
Net loss	`ProfitLoss`	$-46.58M	USD	1 Quarter
Net loss	`ProfitLoss`	$-46.58M	USD	1 Quarter
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-87.00K	USD	1 Quarter
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-87.00K	USD	1 Quarter
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-54.00K	USD	1 Quarter
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-54.00K	USD	1 Quarter
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-37.28M	USD	1 Quarter
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-37.28M	USD	1 Quarter
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-46.52M	USD	1 Quarter
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-46.52M	USD	1 Quarter
Total weighted-average common shares outstanding, net of restricted shares of common stock - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	183.11M	shares	1 Quarter
Total weighted-average common shares outstanding, net of restricted shares of common stock - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	183.11M	shares	1 Quarter
Total weighted-average common shares outstanding, net of restricted shares of common stock - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	189.01M	shares	1 Quarter
Total weighted-average common shares outstanding, net of restricted shares of common stock - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	189.01M	shares	1 Quarter
Total weighted-average common shares outstanding, net of restricted shares of common stock - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	189.01M	shares	1 Quarter
Total weighted-average common shares outstanding, net of restricted shares of common stock - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	189.01M	shares	1 Quarter
Total weighted-average common shares outstanding, net of restricted shares of common stock - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	183.11M	shares	1 Quarter
Total weighted-average common shares outstanding, net of restricted shares of common stock - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	183.11M	shares	1 Quarter
Net loss per share - basic (in dollars per share)	`EarningsPerShareBasic`	$-0.20	USD	1 Quarter
Net loss per share - basic (in dollars per share)	`EarningsPerShareBasic`	$-0.20	USD	1 Quarter
Net loss per share - basic (in dollars per share)	`EarningsPerShareBasic`	$-0.25	USD	1 Quarter
Net loss per share - basic (in dollars per share)	`EarningsPerShareBasic`	$-0.25	USD	1 Quarter
Net loss per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.25	USD	1 Quarter
Net loss per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.25	USD	1 Quarter
Net loss per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.20	USD	1 Quarter
Net loss per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.20	USD	1 Quarter

Cash Flow Statement 142 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-37.37M	USD	1 Quarter
Net loss	`ProfitLoss`	$-37.37M	USD	1 Quarter
Net loss	`ProfitLoss`	$-46.58M	USD	1 Quarter
Net loss	`ProfitLoss`	$-46.58M	USD	1 Quarter
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$1.00K	USD	1 Quarter
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$1.00K	USD	1 Quarter
Provision for credit loss	`ProvisionForDoubtfulAccounts`	-	USD	1 Quarter
Provision for credit loss	`ProvisionForDoubtfulAccounts`	-	USD	1 Quarter
Loss on right of use assets	`GainLossOnSublease`	$-143.00K	USD	1 Quarter
Loss on right of use assets	`GainLossOnSublease`	$-143.00K	USD	1 Quarter
Loss on right of use assets	`GainLossOnSublease`	-	USD	1 Quarter
Loss on right of use assets	`GainLossOnSublease`	-	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$6.03M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$6.03M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$4.98M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$4.98M	USD	1 Quarter
Amortization-investment discount	`InvestmentIncomeAmortizationOfDiscount`	$1.15M	USD	1 Quarter
Amortization-investment discount	`InvestmentIncomeAmortizationOfDiscount`	$1.15M	USD	1 Quarter
Amortization-investment discount	`InvestmentIncomeAmortizationOfDiscount`	$351.00K	USD	1 Quarter
Amortization-investment discount	`InvestmentIncomeAmortizationOfDiscount`	$351.00K	USD	1 Quarter
Amortization-debt issuance costs	`AmortizationOfFinancingCosts`	$305.00K	USD	1 Quarter
Amortization-debt issuance costs	`AmortizationOfFinancingCosts`	$305.00K	USD	1 Quarter
Amortization-debt issuance costs	`AmortizationOfFinancingCosts`	$520.00K	USD	1 Quarter
Amortization-debt issuance costs	`AmortizationOfFinancingCosts`	$520.00K	USD	1 Quarter
Equity-based compensation	`ShareBasedCompensation`	$21.98M	USD	1 Quarter
Equity-based compensation	`ShareBasedCompensation`	$21.98M	USD	1 Quarter
Equity-based compensation	`ShareBasedCompensation`	$20.85M	USD	1 Quarter
Equity-based compensation	`ShareBasedCompensation`	$20.85M	USD	1 Quarter
Non-cash lease expense	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$717.00K	USD	1 Quarter
Non-cash lease expense	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$717.00K	USD	1 Quarter
Non-cash lease expense	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$472.00K	USD	1 Quarter
Non-cash lease expense	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$472.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$45.32M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$45.32M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$32.39M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$32.39M	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$15.79M	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$15.79M	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$8.89M	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$8.89M	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-4.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-4.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$114.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$114.00K	USD	1 Quarter
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$15.54M	USD	1 Quarter
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$15.54M	USD	1 Quarter
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$71.06M	USD	1 Quarter
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$71.06M	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-9.21M	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-9.21M	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$48.00K	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$48.00K	USD	1 Quarter
Deferred premium revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-59.00K	USD	1 Quarter
Deferred premium revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-59.00K	USD	1 Quarter
Deferred premium revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$140.77M	USD	1 Quarter
Deferred premium revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$140.77M	USD	1 Quarter
Accrued compensation	`IncreaseDecreaseInAccruedCompensation`	$-2.50M	USD	1 Quarter
Accrued compensation	`IncreaseDecreaseInAccruedCompensation`	$-2.50M	USD	1 Quarter
Accrued compensation	`IncreaseDecreaseInAccruedCompensation`	$-2.97M	USD	1 Quarter
Accrued compensation	`IncreaseDecreaseInAccruedCompensation`	$-2.97M	USD	1 Quarter
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-755.00K	USD	1 Quarter
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-755.00K	USD	1 Quarter
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-1.11M	USD	1 Quarter
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-1.11M	USD	1 Quarter
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$85.11M	USD	1 Quarter
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$85.11M	USD	1 Quarter
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-6.24M	USD	1 Quarter
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-6.24M	USD	1 Quarter
Purchase of investments	`PaymentsToAcquireInvestments`	$104.24M	USD	1 Quarter
Purchase of investments	`PaymentsToAcquireInvestments`	$104.24M	USD	1 Quarter
Purchase of investments	`PaymentsToAcquireInvestments`	$21.56M	USD	1 Quarter
Purchase of investments	`PaymentsToAcquireInvestments`	$21.56M	USD	1 Quarter
Maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfLongtermInvestments`	$75.39M	USD	1 Quarter
Maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfLongtermInvestments`	$75.39M	USD	1 Quarter
Maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfLongtermInvestments`	$1.10M	USD	1 Quarter
Maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfLongtermInvestments`	$1.10M	USD	1 Quarter
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$7.29M	USD	1 Quarter
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$7.29M	USD	1 Quarter
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$11.12M	USD	1 Quarter
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$11.12M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-110.43M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-110.43M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$42.70M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$42.70M	USD	1 Quarter
Payment of employment taxes related to release of restricted stock	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$350.00K	USD	1 Quarter
Payment of employment taxes related to release of restricted stock	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$350.00K	USD	1 Quarter
Payment of employment taxes related to release of restricted stock	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	-	USD	1 Quarter
Payment of employment taxes related to release of restricted stock	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	-	USD	1 Quarter
Contributions from noncontrolling interest holders	`ProceedsFromMinorityShareholders`	$30.00K	USD	1 Quarter
Contributions from noncontrolling interest holders	`ProceedsFromMinorityShareholders`	$30.00K	USD	1 Quarter
Contributions from noncontrolling interest holders	`ProceedsFromMinorityShareholders`	$15.00K	USD	1 Quarter
Contributions from noncontrolling interest holders	`ProceedsFromMinorityShareholders`	$15.00K	USD	1 Quarter
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$30.00K	USD	1 Quarter
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$30.00K	USD	1 Quarter
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-335.00K	USD	1 Quarter
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-335.00K	USD	1 Quarter
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-25.29M	USD	1 Quarter
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-25.29M	USD	1 Quarter
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$36.13M	USD	1 Quarter
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$36.13M	USD	1 Quarter
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$386.01M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$386.01M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.95M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.95M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$241.09M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$241.09M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$411.30M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$411.30M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$386.01M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$386.01M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.95M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.95M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$241.09M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$241.09M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$411.30M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$411.30M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$5.17M	USD	1 Quarter
Cash paid for interest	`InterestPaidNet`	$5.17M	USD	1 Quarter
Cash paid for interest	`InterestPaidNet`	$4.28M	USD	1 Quarter
Cash paid for interest	`InterestPaidNet`	$4.28M	USD	1 Quarter
Acquisition of property in accounts payable	`AcquisitionOfPropertyInAccountsPayable`	$10.00K	USD	1 Quarter
Acquisition of property in accounts payable	`AcquisitionOfPropertyInAccountsPayable`	$10.00K	USD	1 Quarter
Acquisition of property in accounts payable	`AcquisitionOfPropertyInAccountsPayable`	$156.00K	USD	1 Quarter
Acquisition of property in accounts payable	`AcquisitionOfPropertyInAccountsPayable`	$156.00K	USD	1 Quarter
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$238.90M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$238.90M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$384.26M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$384.26M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$202.90M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$202.90M	USD	Point-in-time
Restricted cash in other assets	`RestrictedCashAndCashEquivalents`	$1.75M	USD	Point-in-time
Restricted cash in other assets	`RestrictedCashAndCashEquivalents`	$1.75M	USD	Point-in-time
Restricted cash in other assets	`RestrictedCashAndCashEquivalents`	$2.18M	USD	Point-in-time
Restricted cash in other assets	`RestrictedCashAndCashEquivalents`	$2.18M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$386.01M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$386.01M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.95M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.95M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$241.09M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$241.09M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$411.30M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$411.30M	USD	Point-in-time

Stockholders Equity 42 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance (in shares)	`CommonStockSharesOutstanding`	191.16M	shares	Point-in-time
Beginning Balance (in shares)	`CommonStockSharesOutstanding`	191.16M	shares	Point-in-time
Beginning Balance (in shares)	`CommonStockSharesOutstanding`	188.95M	shares	Point-in-time
Beginning Balance (in shares)	`CommonStockSharesOutstanding`	188.95M	shares	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$223.94M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$223.94M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$158.07M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$158.07M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$132.02M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$132.02M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$239.30M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$239.30M	USD	Point-in-time
Net loss	`ProfitLoss`	$-37.37M	USD	1 Quarter
Net loss	`ProfitLoss`	$-37.37M	USD	1 Quarter
Net loss	`ProfitLoss`	$-46.58M	USD	1 Quarter
Net loss	`ProfitLoss`	$-46.58M	USD	1 Quarter
Issuance of common stock upon vesting of restricted stock units	`IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsValues`	$2.00K	USD	1 Quarter
Issuance of common stock upon vesting of restricted stock units	`IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsValues`	$2.00K	USD	1 Quarter
Issuance of common stock upon vesting of restricted stock units	`IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsValues`	$1.00K	USD	1 Quarter
Issuance of common stock upon vesting of restricted stock units	`IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsValues`	$1.00K	USD	1 Quarter
Shares withheld related to net restricted stock settlement	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$350.00K	USD	1 Quarter
Shares withheld related to net restricted stock settlement	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$350.00K	USD	1 Quarter
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$20.85M	USD	1 Quarter
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$20.85M	USD	1 Quarter
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$21.98M	USD	1 Quarter
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$21.98M	USD	1 Quarter
Noncontrolling interest attributable to subsidiary	`MinorityInterestDecreaseFromRedemptions`	$-30.00K	USD	1 Quarter
Noncontrolling interest attributable to subsidiary	`MinorityInterestDecreaseFromRedemptions`	$-30.00K	USD	1 Quarter
Noncontrolling interest attributable to subsidiary	`MinorityInterestDecreaseFromRedemptions`	$-15.00K	USD	1 Quarter
Noncontrolling interest attributable to subsidiary	`MinorityInterestDecreaseFromRedemptions`	$-15.00K	USD	1 Quarter
Ending Balance (in shares)	`CommonStockSharesOutstanding`	191.16M	shares	Point-in-time
Ending Balance (in shares)	`CommonStockSharesOutstanding`	191.16M	shares	Point-in-time
Ending Balance (in shares)	`CommonStockSharesOutstanding`	188.95M	shares	Point-in-time
Ending Balance (in shares)	`CommonStockSharesOutstanding`	188.95M	shares	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$223.94M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$223.94M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$158.07M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$158.07M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$132.02M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$132.02M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$239.30M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$239.30M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.